Skip to main content
FinSpry Logo
FinSpry
RCUS logo
RCUS
(NYSE)
Arcus Biosciences, Inc.
$29.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Arcus Biosciences (RCUS) Stock Price & Financial Analysis

Arcus Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$27.97 - $29.68
52-Week High$31.74
52-Week Low$8.88
Open$28.55
Volume1.15M
Average Volume (3M)1.05M
Market Cap3.70B
Shares Outstanding125.40M
Price to Sales (P/S)15.21
Price to Book (P/B)6.85
EV/EBITDA-10.61
Revenue (TTM)236.00M
Net Income (TTM)-369.00M
Free Cash Flow (TTM)-489.00M
EPS (TTM)$-3.31
Profit Margin-156.36%
Operating Margin-168.64%
Return on Equity (ROE)-70.42%
Debt to Equity0.22
50-Day MA$27.35
200-Day MA$23.62
52-Week Change215.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Arcus Biosciences

What is the current stock price for RCUS?

As of the latest trading session, RCUS stock trades at $29.48. The 52-week range is $8.88–$31.74, with a day range of $27.97–$29.68.

What is the P/E ratio for RCUS?

The P/E ratio (Price-to-Earnings) for RCUS is shown in the Key Statistics section. This valuation metric helps compare Arcus Biosciences, Inc. to industry peers.

Does RCUS pay dividends?

Arcus Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RCUS?

Based on 4 analysts, the consensus for RCUS is Buy.

What is the market cap of RCUS?

Arcus Biosciences's market capitalization is $3.70B, classifying it as a mid-cap company. Arcus Biosciences operates in the Healthcare sector within the Biotechnology industry.